Clinical Trials Directory

Trials / Completed

CompletedNCT03699644

Multimodal Ocular Imaging in Neurodegeneration

Status
Completed
Phase
Study type
Observational
Enrollment
16 (actual)
Sponsor
University of Michigan · Academic / Other
Sex
All
Age
45 Years – 80 Years
Healthy volunteers
Accepted

Summary

Alzheimer's disease (AD) and frontotemporal dementia (FTD) are two of the most common types of age-related neurodegenerative disorders. Identifying at-risk patients and gauging disease progression in a non-invasive manner would be invaluable. Early and correct diagnosis is crucial for coordinating supportive care, patient expectations, caregiver arrangements and family planning. In addition, as treatments become available, beginning therapy early in the disease before symptoms become severe will be important. Multimodal ocular imaging (MOI) includes an ophthalmic (eye) exam and eye photographs to evaluate different layers of the retina, which is the light sensing layer of the eye. Newer technologies make it possible to visualize the disease process occurring in AD and FTD by using MOI to look at the retina, since the retina is fundamentally an outward extension of the brain itself. This study will attempt to correlate signs of disease in the retina, as determined by MOI, with plaque buildup in the brain as seen by imaging. This will demonstrate the sensitivity and specificity of MOI for diagnosing AD and FTD in a noninvasive manner.

Conditions

Interventions

TypeNameDescription
DEVICESpectral-Domain Optical Coherence Tomography (SD-OCT)Each participant in this study will undergo Optical coherence tomography (OCT), a non-invasive imaging test of the eye, one time. OCT uses light waves to take cross-section pictures of the retina, which are generated using scattered light waves.
DEVICEMagnetic Resonance Imaging (MRI)Each participant in this study will undergo a single Magnetic resonance imaging (MRI) scan, a scanning technique for creating detailed images of the human body. The scan uses a magnetic field and radio waves to generate images of the brain.
DEVICEPositron Emission Tomography (PET)Each participant in this study will undergo a single Positron emission tomography (PET) scan of the brain. PET is a nuclear medicine functional imaging technique that is used to observe metabolic processes in the brain as an aid to the diagnosis of disease using the combination of a radioactive tracer, camera, and a computer.
DIAGNOSTIC_TESTComprehensive Ophthalmic ExaminationEach participant in this study will receive one comprehensive eye examination which will be performed by a licensed ophthalmologist at the University of Michigan. This examination will include the assessment of the participant's visual acuity, a slit lamp examination which will look at the anterior and posterior tissues of the eye including the retina using various lights and lenses, and intraocular pressures.
DEVICEFundus PhotographyEach participant in this study will undergo fundus photography of each eye. Fundus photography involves the use of a retinal camera coupled with a low power microscope to capture photographs of the retina.

Timeline

Start date
2019-01-04
Primary completion
2019-04-03
Completion
2019-04-03
First posted
2018-10-09
Last updated
2022-03-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03699644. Inclusion in this directory is not an endorsement.